Egle Therapeutics at EADV 2026
Our team will be attending the 35th Congress of the European Academy of Dermatology and Venereology (EADV), taking place September 30 – October 3, 2026, in Vienna, Austria.
Discover our latest clinical data on EGL-003, our Treg-selective IL-2 agonist, presented as an ePoster.
Abstract / ePoster: AS-3660 / P1719
Title: EGL-003 First in Human Study: An IL-2 Mutein inducing potent and selective amplification of Treg with preferential activation of effector/memory skin homing Tregs